Recap: Anika Therapeutics Q1 Earnings

Anika Therapeutics ANIK reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Anika Therapeutics missed estimated earnings by 20.0%, reporting an EPS of $-0.36 versus an estimate of $-0.3.

Revenue was up $1.23 million from the same period last year.

Last quarter the company beat on EPS by $0.03 which was followed by a 10.25% drop in the share price the next day.

Here's a look at Anika Therapeutics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.24	-0.25	-0.23	-0.36
EPS Actual	-0.21	-0.05	-0.12	-0.11
Revenue Estimate	37.70M	37.59M	37.85M	32.90M
Revenue Actual	39.62M	40.26M	39.66M	36.69M

To track all earnings releases for Anika Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar